More than 100,000 people are diagnosed with skin cancer each year in the US.

Skin Cancer

With the arrival of the summer season and the increase in outdoor activities, health experts warn about the importance of taking seriously the threat of melanoma, the deadliest type of skin cancer that affects one in five Americans at some point in their lives.

Melanoma, fueled by exposure to the sun's ultraviolet rays, represents a significant public health risk. According to the American Cancer Society, approximately 100,000 people are diagnosed with melanoma each year in the United States, and about 8,000 die from the disease annually.

Dr. Michael Davies, chair of the Department of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center, emphasizes the aggressive nature of melanoma and the importance of early detection to improve survival rates.

Melanoma usually starts in skin cells called melanocytes, which produce skin pigment. Although it can appear anywhere on the body, it is most common in areas exposed to sunlight, such as the face, neck, arms, and legs.

Dr. Shanthi Sivendran, a medical oncologist and senior vice president of the American Cancer Society, highlights that exposure to ultraviolet light, whether from the sun or tanning beds, is a major risk factor. It urges avoiding unnecessary exposure and taking precautions, such as using sunscreen and protective clothing.

Also Read: Salt Replacement Linked to Lower Risk of Premature Death

In addition, the importance of early detection of melanoma is highlighted. Although there are no standard guidelines, people are encouraged to perform regular skin self-examinations and to watch for changes in moles or the appearance of new lesions.

Dr. Kelly Nelson, dermatologist at MD Anderson Cancer Center, emphasizes the importance of education about melanoma screening and promoting awareness of the warning signs.

In terms of treatment, medical advances have revolutionized the management of melanoma in recent years. Options range from surgical removal of early-stage cancer to more advanced therapies that harness the immune system or directly attack cancer cells.

Recently, the Food and Drug Administration approved an innovative treatment that uses tumor-infiltrating lymphocytes to combat melanomas resistant to other treatments. Additionally, late-stage clinical trials are underway to test personalized vaccines that are tailored to the specific genetic makeup of each patient's cancer.

As summer progresses, experts are urging people to take preventive measures against melanoma and to be alert for any skin changes that may indicate the presence of this potentially deadly disease. Awareness and education are critical to addressing this public health issue and saving lives.